Exelixis (EXEL) Amortization of Deferred Charges (2015 - 2017)
Exelixis (EXEL) posted quarterly Amortization of Deferred Charges of $93000.0 for Q2 2017, down 17.7% year-over-year from $113000.0 in Q2 2016, and up 4.49% quarter-over-quarter from $89000.0 in Q1 2017.
Analysis
Exelixis (EXEL) Amortization of Deferred Charges (2015 - 2017) Analysis & Trends
Exelixis' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $93000.0 for Q2 2017.
- In Q2 2017, Amortization of Deferred Charges fell 17.7% year-over-year to $93000.0; the TTM figure through Jun 2018 stood at $93000.0 (up 101.68% YoY), while the FY2017 annual figure was $182000.0, down 97.84% from the prior year.
- Amortization of Deferred Charges for Q2 2017 stood at $93000.0, up from $89000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $4.8 million in Q2 2015, with the low at -$5.8 million in Q4 2016.
- The 3-year median for Amortization of Deferred Charges is $117000.0 (2016), against an average of $687125.0.
- The sharpest annual moves came in 2016 and 2017: Amortization of Deferred Charges slumped 97.66% in 2016, then decreased 17.7% in 2017.
- Exelixis' Amortization of Deferred Charges stood at $2.9 million in 2015, then sank by 299.45% to -$5.8 million in 2016, then surged by 101.59% to $93000.0 in 2017.
- Business Quant data shows EXEL's Amortization of Deferred Charges at $93000.0 in Q2 2017, $89000.0 in Q1 2017, and -$5.8 million in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 93,000.00 |
| Mar 31, 2017 | 89,000.00 |
| Dec 30, 2016 | 137,000.00 |
| Sep 30, 2016 | 121,000.00 |
| Jun 30, 2016 | 113,000.00 |
| Mar 31, 2016 | 3.16 Mn |
| Sep 30, 2015 | 2.93 Mn |
| Jun 30, 2015 | 4.83 Mn |